ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2023

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2023
NameSharesValueWeighting ↓
Caption Management, LLC 22,500$802,1250.01%
WCM INVESTMENT MANAGEMENT, LLC 107,765$3,854,7540.01%
B. Metzler seel. Sohn & Co. AG 21,080$751,5020.01%
MACQUARIE GROUP LTD 217,236$7,744,0000.01%
BNP PARIBAS FINANCIAL MARKETS 214,275$7,638,9040.01%
Column Capital Advisors, LLC 1,704$60,7480.01%
CREDIT SUISSE AG/ 248,717$8,866,7600.01%
ESSEX INVESTMENT MANAGEMENT CO LLC 1,481$52,7980.01%
TD ASSET MANAGEMENT INC 205,360$7,321,0840.01%
State of New Jersey Common Pension Fund D 68,337$2,436,2140.01%
NATIXIS 33,100$1,180,0150.01%
Point72 Middle East FZE 7,243$258,2040.01%
Cubist Systematic Strategies, LLC 29,178$1,040,2050.01%
GUGGENHEIM CAPITAL LLC 25,757$918,2370.01%
New Millennium Group LLC 200$7,1300.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 90,000$3,208,5000.01%
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 84,482$3,011,7840.01%
Arizona State Retirement System 20,163$718,8110.01%
STATE OF WISCONSIN INVESTMENT BOARD 56,593$2,017,5400.01%
VANGUARD GROUP INC 7,233,168$257,862,4400.01%
External links

This page lists ULTRAGENYX PHARMACEUTICAL IN's shareholders in Q3 2023. To view ULTRAGENYX PHARMACEUTICAL IN's shareholder history, click here.